OrfoXen (Orforglipron)

Orforglipron is a once-daily oral GLP-1 medicine developed for long-term weight management. Unlike injectable GLP-1 treatments, it comes in tablet form, making it a convenient option for people who prefer not to use injections. It works by activating GLP-1 receptors involved in appetite, fullness and blood-sugar regulation. This can help you feel satisfied with less food, control hunger more easily and maintain a calorie deficit for sustainable weight loss. Why People Choose Orforglipron Reduces appetite and food cravings Helps you feel full for longer Supports meaningful weight and body-fat reduction Convenient oral tablet – no injections required Supports healthier blood-sugar and metabolic control Designed for long-term weight-management support How Well Does It Work for Weight Loss? Large Phase 3 clinical trials have shown significant weight reduction when Orforglipron was combined with a reduced-calorie diet and regular physical activity. In a 72-week obesity study, average weight loss ranged from approximately 7.5% to 11.2% of starting body weight across the treatment groups, compared with around 2% with placebo. Individual results vary, and Orforglipron works best alongside good nutrition, regular activity and sustainable lifestyle changes. Possible Side Effects The most commonly reported side effects are similar to other GLP-1 medicines and mainly involve digestion, including: Nausea Diarrhoea Constipation Indigestion Vomiting These effects are commonly more noticeable when treatment is started or adjusted.